Literature DB >> 12451259

Role of CD4+ and CD8+ T cells in the rejection of concordant pancreas xenografts.

Deng-Ping Yin1, Lian-Li Ma, Howard N Sankary, Jikun Shen, Huasong Zeng, Anncy Varghese, Anita S Chong.   

Abstract

BACKGROUND: We studied the ability of CD4 and CD8 T cells to induce rejection of pancreas xenografts in a concordant combination using rat pancreas xenografts as donors and chemically induced diabetic mice as recipients.
METHODS: Lewis rat (2 to 3 weeks old) pancreas xenografts were transplanted into streptozotocin (STZ)-induced diabetic mice. Lymphocyte proliferation and cytokine production were analyzed in vitro. All pancreas xenografts were assessed by functional (blood glucose) and histopathologic examinations.
RESULTS: Lewis rat pancreas grafts were rejected within 10 to 13 days, with mononuclear cell infiltrate and tissue necrosis in STZ-induced diabetic mice. A predominant T cell receptor alphabeta -CD4 cell (on day 4) and T cell receptor alphabeta -CD8 cell (on day 8) infiltrate and IgM deposition were found in the pancreas xenografts after transplantation. Anti-CD4 (GK1.5), but not anti-CD8 (YTS169.4), monoclonal antibodies resulted in a prolonged survival of Lewis rat pancreas xenografts. Lewis pancreas xenografts were permanently accepted by CD4 knockout mice but not by CD8 knockout mice. The pancreas xenografts were acutely rejected with a mean survival time of 15.3 days in B cell-deficient mice (microMT/microMT). Transfer of CD4 but not CD8 spleen cells from naïve C57BL/6 mice into Rag2 mice led to acute rejection of transplanted pancreas xenografts. However, activated CD8 spleen cells elicited rejection of Lewis rat pancreas xenografts in SZT-induced diabetic mice.
CONCLUSION: The current results show that CD4 T cells are necessary and sufficient for mediating the rejection of Lewis rat pancreas xenografts in STZ-induced diabetic mice. However, CD8 cells, when activated, can also induce acute rejection of concordant pancreas xenografts.

Entities:  

Mesh:

Year:  2002        PMID: 12451259     DOI: 10.1097/00007890-200211150-00007

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

1.  Common and small molecules as the ultimate regulatory and effector mediators of antigen-specific transplantation reactions.

Authors:  Vladimir Holan; Magdalena Krulova
Journal:  World J Transplant       Date:  2013-12-24

2.  Effector mechanisms of the autoimmune syndrome in the murine model of autoimmune polyglandular syndrome type 1.

Authors:  Jason J Devoss; Anthony K Shum; Kellsey P A Johannes; Wen Lu; Anna K Krawisz; Peter Wang; Ting Yang; Norbert P Leclair; Cecilia Austin; Erich C Strauss; Mark S Anderson
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

3.  CD4+ T cells are sufficient to elicit allograft rejection and major histocompatibility complex class I molecule is required to induce recurrent autoimmune diabetes after pancreas transplantation in mice.

Authors:  Zhidan Xiang; Lian-Li Ma; Santhakumar Manicassamy; Balaji B Ganesh; Phillip Williams; Ravi Chari; Anita Chong; Deng-Ping Yin
Journal:  Transplantation       Date:  2008-04-27       Impact factor: 4.939

4.  Spontaneous autoimmunity prevented by thymic expression of a single self-antigen.

Authors:  Jason DeVoss; Yafei Hou; Kellsey Johannes; Wen Lu; Gregory I Liou; John Rinn; Howard Chang; Rachel R Caspi; Rachel Caspi; Lawrence Fong; Mark S Anderson
Journal:  J Exp Med       Date:  2006-11-20       Impact factor: 14.307

5.  A preclinical evaluation of alternative site for islet allotransplantation.

Authors:  Chengshi Wang; Xiaojiong Du; Sirong He; Yujia Yuan; Pengfei Han; Dan Wang; Younan Chen; Jingping Liu; Bole Tian; Guang Yang; Shounan Yi; Fabao Gao; Zhihui Zhong; Hongxia Li; Jingqiu Cheng; Yanrong Lu
Journal:  PLoS One       Date:  2017-03-30       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.